… tive review, we analyze the data regarding the sequence of chemotherapy and radiation
therapy and its effect on local and systemic recurrences in patients with operable breast cancer. …

… Dose-dense paclitaxel-based therapy, in which chemotherapy cycles are administered
every 2 weeks has produced impressive results in the adjuvant setting. It remains to be …

… chemotherapy administration. Three trials described herein directly addressed this
question by comparing an anthracycline-containing regimen and a sequential anthracycline-taxane …

… cancer and the second leading cause of cancer-related mortality (after lung cancer) with
more than 200,000 new breast cancer … randomization to trastuzumab administered for only 9 …

… amount of CMF administered was planned, and we found that the percentage of the planned
dose that was given had a major influence on the results of chemotherapy in breast cancer, …

… investigated the quality of chemotherapy administration in minority and/or low-income breast
cancer patients. Despite success in the treatment of early-stage breast cancer, racial and …

… administered by low dose continuous intravenous infusion results in substantial antitumor
activity in metastatic breast … resistant to 5-fluorouracil administered by bolus or by short …

… chemotherapy administration, even at lower doses, might prove effective as anticancer
therapy. Weekly paclitaxel dosing at 80 to 100 mg/m 2 has demonstrated single agent response …

… means of increasing the effect of chemotherapy. One theoretically … chemotherapy
administration. This approach consists of multiple cycles of escalated-dose chemotherapy …

… is the most frequently used drug in breast cancer with proven apoptotic effect on … breast
cancer, we used BALB/c mice inoculated sc with 10 6 DA3-HA cells. Paclitaxel was administered …